These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8899738)
1. Antiallodynic effects of a CCKB antagonist in rats with nerve ligation injury: role of endogenous enkephalins. Nichols ML; Bian D; Ossipov MH; Malan TP; Porreca F Neurosci Lett; 1996 Sep; 215(3):161-4. PubMed ID: 8899738 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors. Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354 [TBL] [Abstract][Full Text] [Related]
3. Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat. Ossipov MH; Kovelowski CJ; Vanderah T; Porreca F Neurosci Lett; 1994 Nov; 181(1-2):9-12. PubMed ID: 7898778 [TBL] [Abstract][Full Text] [Related]
4. Antisense oligodeoxynucleotide to the CCKB receptor produces naltrindole- and [Leu5]enkephalin antiserum-sensitive enhancement of morphine antinociception. Vanderah TW; Lai J; Yamamura HI; Porreca F Neuroreport; 1994 Dec; 5(18):2601-5. PubMed ID: 7696612 [TBL] [Abstract][Full Text] [Related]
5. Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats. Nichols ML; Bian D; Ossipov MH; Lai J; Porreca F J Pharmacol Exp Ther; 1995 Dec; 275(3):1339-45. PubMed ID: 8531101 [TBL] [Abstract][Full Text] [Related]
6. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone. Ossipov MH; Kovelowski CJ; Wheeler-Aceto H; Cowan A; Hunter JC; Lai J; Malan TP; Porreca F J Pharmacol Exp Ther; 1996 May; 277(2):784-8. PubMed ID: 8627559 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats. Coudoré-Civiale MA; Méen M; Fournié-Zaluski MC; Boucher M; Roques BP; Eschalier A Br J Pharmacol; 2001 May; 133(1):179-85. PubMed ID: 11325808 [TBL] [Abstract][Full Text] [Related]
8. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats. Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929 [TBL] [Abstract][Full Text] [Related]
9. A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test. Noble F; Blommaert A; Fournié-Zaluski MC; Roques BP Eur J Pharmacol; 1995 Jan; 273(1-2):145-51. PubMed ID: 7737308 [TBL] [Abstract][Full Text] [Related]
10. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study. Sullivan AF; Hewett K; Dickenson AH Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067 [TBL] [Abstract][Full Text] [Related]
11. Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the delta opioid system in the nucleus accumbens of rat. Daugé V; Samir A; Cupo A; Roques BP Neuropharmacology; 1999 Jul; 38(7):999-1007. PubMed ID: 10428418 [TBL] [Abstract][Full Text] [Related]
12. The increase in morphine antinociceptive potency produced by carrageenan-induced hindpaw inflammation is blocked by naltrindole, a selective delta-opioid antagonist. Ossipov MH; Kovelowski CJ; Porreca F Neurosci Lett; 1995 Jan; 184(3):173-6. PubMed ID: 7715840 [TBL] [Abstract][Full Text] [Related]
13. Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy. Gustafsson H; Afrah AW; Stiller CO J Neurochem; 2001 Jul; 78(1):55-63. PubMed ID: 11432973 [TBL] [Abstract][Full Text] [Related]
14. Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively. Takemori AE; Portoghese PS Eur J Pharmacol; 1993 Sep; 242(2):145-50. PubMed ID: 8253111 [TBL] [Abstract][Full Text] [Related]
15. CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101. Dauge V; Corringer PJ; Roques BP Pharmacol Biochem Behav; 1995 Feb; 50(2):133-9. PubMed ID: 7740050 [TBL] [Abstract][Full Text] [Related]
16. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo. Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648 [TBL] [Abstract][Full Text] [Related]
17. Feedback inhibition of met-enkephalin release from the rat spinal cord in vivo. Collin E; Bourgoin S; Mantelet S; Hamon M; Cesselin F Synapse; 1992 May; 11(1):76-84. PubMed ID: 1604425 [TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin receptor agonists block the jumping behaviour precipitated in morphine-dependent mice by naloxone. Bourin M; Malinge M; Colombel MC; Vasar E Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):37-43. PubMed ID: 10082226 [TBL] [Abstract][Full Text] [Related]
19. [Role of delta opioid receptors and their ligands in the development of adaptive heart protection against arrhythmogenesis]. Naryzhnaia NV; Krylatov AV; Maslov LN; Lishmanov IuB; Gross GJ; Stephano JB Ross Fiziol Zh Im I M Sechenova; 2001 Dec; 87(12):1617-25. PubMed ID: 11845802 [TBL] [Abstract][Full Text] [Related]
20. The role of delta-opioid receptor subtypes in neuropathic pain. Mika J; Przewłocki R; Przewłocka B Eur J Pharmacol; 2001 Mar; 415(1):31-7. PubMed ID: 11245849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]